A series of our researches revealed that a Bryophyte, Marchantia polymorpha, contained steroidal plant hormones, collectively named brassinosteroids (BRs), such as 6-deoxocastasterone (7), castasterone (8) and brassinolide (9), 1,2 and potent biosynthetic precursors of the BRs, campesterol (1) and campestanol (2).
H0]-6-deoxotyphasterol (6), a potent biosynthetic precursor of 7, in cultured cells of M. polymorpha in this study, 10, 11 which gives information on biosynthetic processes for A-ring hydroxylation to produce the BRs identified from the lower plant.
First, [
2 H6]-6 was fed to the media of suspension cultured cells of M. polymorpha to investigate in vivo conversion of 6 in the lower plant. After incubation for 7 days, the cells were harvested and extracted with 80% methanol followed by chloroform. The extract was reduced to aqueous phase, combined with the media, and purified by column chromatographies by the guidance of the rice lamina inclination assay. 12 The final purification for metabolites of [ H6]-6 in the Marchantia cells. The fractions were thus derivatized to be a methaneboronate (MB) or MB-trimethylsilylic ether (TMSi), and then analyzed by GC-MS/Selected Ion Monitoring (SIM).
As summarized in Table 1 (Table 1 ). In the HPLC fraction 50-52, a MB-TMSi and a MB of the product gave the identical mass spectrum and GC retention time to those of authentic 4 MB-TMSi and 5 MB, respectively (Table 1) . Coupled with the result obtained from in vivo feeding experiment, these revealed that 6 was converted into 7 by 2α-hydroxylation, and 4 via 5 by C6-oxidation and C3-epimerization. Therefore, the presence of a biosynthetic sequence, 4 ← 5 ← 6 → 7, was demonstrated in the cells (Table 2 ).
In the late C6-oxidation pathway, 3-epimerization of 4 to 6 via 5 is known to be a reversible reaction. 11, 13 Thus, the presence of 6 → 5 → 4 strongly suggested that a reversed reaction of the sequence can be also functional in the Marchantia cells. To confirm that, enzymatic conversions of 4 and 5 in the cells were subsequently performed. When 4 was added to the enzyme solution as a substrate, 5 and 6 were identified as the products. When 5 was used, 4 and 6 were characterized to be the products (Table 2) . These indicated that conversions of 4 → 5 → 6 and 4 ← 5 → 6 also occurred in the cells, proofing the presence of a reversible 3-epimerization of 4 to 6 via 5, 4 ↔ 5 ↔ 6, in the Marchantia cells.
The activity of enzymes mediating the conversion of 4 to 6 via 5 and 6 to 7, namely 4 dehydrogenase (c), 5 reductase (d) and 6 2α-hydroxylase (e), respectively, in the Marchantia cells calculated by the ratio of the products to the internal standards ([   2   H6 ]-4, -5 and -7) added was 100.0, 57.9 and 23.5 ng mg protein
, respectively, which are much higher than that of 7 oxidase (f, 5.9 ng mg protein −1 min −1 ) and 8 6-oxidase (g, 0.6 ng mg protein −1 min −1 ) previously determined in the cells. 9 This probably means that 4 is quickly converted into 7 via 5 and 6, but the next conversion of 7 to 9 via 8 slowly occurs. For the reason, the endogenous level of 7, 8 and 9 seems to be kept higher than those of 4, 5 and 6 in the Marchantia cells, which probably allowed us to identify 7, 8 and 9 but not 4, 5 and 6 from M. polymorpha.
1,2
Although 4, 5 and 6 has not been identified from M. polymorpha, the presence of a biosynthetic sequence of BRs, 4 ↔ 5 ↔ 6 → 7, in the Marchantia cells was demonstrated by in vivo and vitro conversions in this study. Because the presence of biosynthetic sequences, 1 → 2 and 7 → 8 → 9, was already verified in the cells, 1-3 the result indicates that M. polymorpha contains biosynthetic sequences, 1 → 2 and 4 ↔ 5 ↔ 6 → 7 → 8 → 9, to produce BRs. These biosynthetic sequences are included in the C6-oxidation pathway established in higher plants, which suggests that the same biosynthetic pathway in higher plants is working to produce BRs in a liverwort, M. polymorpha. Therefore, it is thought that the biosynthetic pathway to BRs in higher plants, at least the C6-oxidation pathway, is evolved from that in lower plants. To complete the genesis of BRs biosynthesis in plant kingdom, demonstration of the presence of the skipped biosynthetic pathway from 2 to 4 via 3 in Marchantia cells is underway now.
Experimental Section
Purification of in vivo metabolites of [ 10 After 1 week, the cells were harvested and extracted with 80% methanol (100 mL × 3). The extract was reduced to aqueous phase, combined with the culture media (30 mL), and re-extracted with chloroform (100 mL × 3). The chloroform soluble extract was concentrated and partitioned between n-hexane and 80% methanol. The biological active 80% methanol fraction was evaporated, and partitioned again between phosphate buffer (0.1 M, pH 7.8) and ethyl acetate. The ethyl acetate soluble fraction was then loaded on a silica gel (20 g, Merck Co.) column. Elution was carried out with every 100 mL of chloroform, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 50% methanol in chloroform. The fraction 4-6% methanol in chloroform shown BR-activity was combined and subjected to C18 bulk chromatography (100 mL, Waters, Preparative C18) that was eluted with 50, 60, 70, 80, 90 and 100% methanol. The fraction eluted 70-90% methanol was further purified by a reversed phase HPLC (Senshu Pak Pegasil-B, 10 × 150 mm) at a flow rate 2.5 mL min −1 using aqueous acetonitrile as a mobile phase (0-20 min: 45%, 20-40 min: gradient to 100%, and then 100%). The HPLC fractions were collected every min, and analyzed by a Preparative F254 TLC (Merck. Co) developed with a mixture of methanol-chloroform (1 : 6). After treatment of 70% sulfuric acid followed by heating, BR-like purplebluish spots were detected in the HPLC fraction 42-43, 50-52 and 55-56. The fractions were analyzed by GC-MS/SIM.
Enzyme preparation and assay. Suspension cultured cells (15 g) of M. polymorpha were homogenized with Naphosphate buffer (pH 7.4) containing 250 mM sucrose, 15 mM 2-mercaptoethanol, 1 mM EDTA, 40 mM ascorbate, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 15% (v/v) glycerol and 1% (w/v) insoluble polyvinylpyrrolidone. The homogenate was filtered and centrifuged at 15,000 × g for 20 min. The resulting supernatant was collected and used as a crude enzyme solution to examine enzymatic transformations in the study.
In vitro enzymatic conversions were undertaken by addition of 6 (5 µg × 3) to the crude enzyme solution (500 µL × 3) The assay mixture was incubated at 37 o C from 30 min, and enzyme products were extracted with ethyl acetate after adding [ 2 H 6 ]-4, -5 and -7 as internal standards for quantitative analysis. The obtained ethyl acetate soluble fraction was concentrated, re-dissolved in 50% methanol (10 mL), and loaded on Sep-Pak C18 (Waters Co.) cartridge eluted with aqueous methanols (10 mL each, 50, 60 and 100%). The fraction eluted with 100% methanol that showed a BR-activity was subjected to a reversed phase HPLC (Senshu Pak Pegasil-B, 10 × 150 mm) at a flow rate 2. 
